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Results: TB cases notified by clinicians were 461 (1996) and 477 
(1997). Cases notified by laboratories alone were an additional 27 in 
1996 (total of488) and an additional 11 in 1997 (total 488). The inci- 
dence of infection due to laboratory notification had an increase of 
0.7/100.000 inh in 1996 and 0.3/100.000 inh. in 1997. Thus the 
global increase due to laboratories has been Kin 1996 and 2.5% in 
1997. 
Conclusions: Even in tuberculosis infection the laboratories of 
microbiology can improve the collection of epidemiologic data and 
contribute to enhancing the efficiency of the prevention programs. 
(p11551 Enterobacter cloacae-the new problem in 
nosocomial infections in the State Clinical 
Hospital No. 1 in Gdansk 
A. Sledzinska', A. Samet', A. Hellmann', M. Btonk, K. Gizynski'. 
'Department of Clinical Bacteriology, State Clinical Hospital No. 1 ,  
Gdansk, IAdult 's Hematologic Unit, Gdansk Medical University, 
Gdansk, Poland 
Objectives: Analysis of multiresistant strains of Enterobacter cloacae. 
Materials and methods: We analyzed 120 multiresistant isolates 
of E. cloacae. They came from patients hospitalized in the following 
units: Adult's Hematologic, Pediatry Intensive Care, and Plastic 
Surgery. 40 isolates were isolated from blood, and 80 from the other 
specimens: stool, urine, bronchial tree, and pharyngeal swab. 
Phenotypes were determined by GNI card, API 20E (bioMCrieux). 
Antibiotic susceptibility was determined by disk difisio, a microdi- 
lution automatic method (VITEK system, bioMCrieux), GNS- 
NX/NT cards, and a microdilution method (Sceptor, Becton 
Dickinson). 
Results: In 1997, multiresistant strains of E .  cloacae were restricted 
to the Hematologic Unit. Then it appeared in the other units of the 
hospital. 83 of the multiresistant isolates of Enterobacter cloacae were of 
the phenotypes 3031772362 (GNI), and 3304573 (API 20E). They 
were sensitive to imipenem and meropenem; MIC <= 4 pg/mL). 
37 strains were ofthe phenotypes 3031770362 (GNI), and 33304773 
(API 20E). They were sensitive also to trimethoprim/sulfamethoxa- 
zole (MIC <= 0.519.50 pg/mL), gentamicin (MIC <= 1 pg/mL), 
tobramycin, and arnikacin (MIC <= 4 pg/mL). 
Conclusions: The incidence of multiresistant strains of E. cloacae 
is the result of uncontrolled usage of antibiotics, and set schemes of 
antibiotic therapy in patients after bone marrow transplantation. The 
incidence of these isolates in the other units was due to their spread 
from the Hematologic Unit. 
1- Rapid susceptibility testing of Gram-positive 
organisms: a preliminary study of the 
Phoenix System 
T. Wiles, W. Brasso, D. Turner, D. Holliday, K. Fischbein. Becton 
Dickinson Microbiology Systems, Sparks, M D ,  USA 
Objectives: To evaluate the use of a new ID/AST System, Phoenix, 
to determine the susceptibility of Gram-positive organisms. 
Methods: A total of 246 Gram-positive cocci were tested in paral- 
lel using the Phoenix system and a standard broth microdilution 
procedure (SBM). The challenge set consisted of 121 Enterococcus and 
125 Staphylococcus isolates. Eight doubling dilutions of 10 antimicro- 
bial agents were evaluated in this study. The Phoenix panels were 
inoculated with 5 xl0' CFU/niL and tested in the prototype 
Phoenix instrument. Kinetic readings were obtained in the Phoenix 
system up to 16 h. 
Results: The overall essential agreement (EA) was 93% with SBM 
and ranged between 91% and 99% for the different agents. The 
numbers of very major, major and minor errors were determined to 
be I .7%, 0.7%, and 2.7%, respectively Results for 95% ofthe isolates 
were available between 5 and 8 h, and for the remainder by 14 h. 
The essential agreement for staphylococci (n= 125) for gentamicin, 
SXT, oxacillin, clindamycin and erythromycin was 95%, 94%, 94%, 
98% and 90% respectively. For enterococci and staphylococci 
(n=246), the EA for ampicillin, penicillin, ciprofloxacin, tetracycline 
and vancomycin was determined to be 96%, 93%, 98%, 99% and 91% 
respectively 
Conclusions: The automated Phoenix system should provide 
accurate and rapid susceptibility results for Enterococcus and Staphy- 
lococccrs species. 
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m] Characterization of Candida isolates from 
blood cultures 
G. Schroder, B. Panzig, H. Bernhardt, K. Schulz, F. Feyerherd. 
Znstirnte of Medical Microbiology, Greijfswald, Germany 
Objectives: The isolation rate of Candida spp. in blood cultures was 
investigated over a period of 3 years in comparison with bacteria. The 
susceptibility of fluconazole of Candida isolates was determined. 
Methods: From 1955 to 1998,33 858 blood cultures were exam- 
ined using BACTEC 9240 (Becton Dickinson GmbH, Heidel- 
berg).The identification of Candida species was carried out with the 
Vitek System (bioMerieux Deutschland GmbH, Niirtingen). The 
susceptibility to fluconazole was determined by the microdilution 
technique. 
Results: 5% (142/2807) of all detected microorganisms were 
Candida spp. An elevated percentage of 13.2% (66/499) was observed 
in blood cultures from surgical intensive care units (ICU). 57 patients 
(50 adults/7 children) with candidemia were evaluated. The follow- 
ing species were isolated C. albicans in 38 patients, C. glabrata in 11, 
C. parapsilosis in 2, C. tropicalis in 2, C. lusituniae in 2, and C. guillier- 
mondii in 2. There were differences in the distribution of Candida 
species between the ICU (38 patients), and pediatric (7) and other 
clinical wards (12). Overall, C. albicans was the most isolated species, 
and C. glabrata (10/11) was more frequent in patients h m  the ICU. 
In 84% of ICU patients with candidemia, the same species was 
isolated from additional materials. AU isolated C. albicans strains were 
susceptible to fluconazole (MIC value <1.5 mg/L). In comparison 
to C. albicans strains, the MICs of C. glabrata strains varied between 
< 1.5 and 25 mg/L. 
Conclusions: The predominant species isolated from blood 
cultures was C. albicans. C. glabrata has just emerged as an important 
species in candidemia of ICU patients. 
m) Reduction of anticandidal cellular immune 
response in women with recurrent 
vulvovaginal candidiasis (RWC) 
U. Nawrot, K. Grzybek-Hryncewicz, W. Smogor. Department of 
Microbiology, Medical University of Wroclaw, Wroclaw, Poland 
Objectives: To determine lymphocyte proliferation and IFN, TNF 
and IL-6 production by WBC (whole blood cells) of patients with 
RVVC in response to stimulation of Candida antigen and mitogens. 
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Methods: The study group included 37 patients with a syrnpto- 
matic episode of recurrent Condida vaginitis, 14 patients in the reinis- 
sion phase of RWC (asymptomatic KVVC) and 25 healthy women. 
Induction of proliferation and cytokiiie production were perfbrmed 
by heat-killed Candida cells and mitogens: PHA or LPS. Proliferation 
ofl'BMC was evaluated after 5 days of culture using the MTT colori- 
metric method. IFN, T N F  and 1L-6 were quantitated in the super- 
natants of WBC culture using a bioassay method. Results were 
compared using the Wilcoxon test. 
Results: Proliferation and production of IFN and TNF stimulated 
by Candida were significantky lower in patients with syniptoinatic 
RVVC than in patients with asymptomatic RWC (p10.05, p<O.OOl 
respectively) and in healthy individuals (p<0.001, p<0.005, p<0.01 
respectively). There was no significant difference between patients 
and controls in Candida-stitiiulated IL-6 production, and in prolifer- 
ation and IFN production in response to PHA and TNE and IL-6 
production in response to LPS. 
Conclusions: Wonien with symptomatic RVVC have reduced 
Cawdida-specific cellular responses (proliferation and IFN produc- 
tion) compared with asymptomatic KVVC and with control<. 
Ip116Ol Complementation of anti-Candida rnannan 
antibodies and rnannanemia detection tests 
for the diagnosis of systemic candidiasis 
B. Sendid', M. Tabouret', J.L. Poirot', D. Poulain'. 'Laboratoire de 
MycoloXie Fondanzentale ef AppliquPe, CHU, Facult4 de M4decine, Lille, 
'Sam$ Diqwostics Pastew, Stecwoorde, -'Laboratoire de Parasifolo~qie- 
Mytologic,, Hipita/ Saint Antoitre, Paris, France 
Objectives: To assess the perforniances of new EIA tests for 
niannanemia and anti-iiiannan antibody detection for the diagnosis 
of systemic candidiasis. 
Patients and methods: Two EIA tests were developed jointly. 
Platelia Candida antibody consisted of the detection of antibodies (A, 
G, M) directed against mannan extracted from C. albicatrs strain 
VW32. Platelia Candida antigen used rat monoclonal antibody 
EBCAl as captor and detector for the detection of mannail in sera 
after heat dissociation of the iinniune complexes. Patients' sera 
consisted of 253 sera retrospectively selected from 71 patients with 
candidiasis proven by biopsy or culture from normally sterile sites. 
Forty-three patients were infected by C. nlbicans and 28 by other non- 
albicatis species. Control sera consisted of 93 sera drawn froin 23 
hospitalized patients presenting no evidence of candidiasis; 39 sera 
from patients with deep niycoses (invasive pulmonary aspergillosis 
( t i=  12), cryptococcal meuingitis ( i z=  13), Pneirmoiystis c'iritzii pneu- 
monia (n=4)); and 98 sera from 98 healthy blood donors. 
Results: When infections caused by C. albiians, C. glabrata, and 
C. tropiialis were considered, sensitivity and specificity were 45/98% 
aiid 55/94% for iiiannaneniia or antibody detection, respectively. The 
combined use of both tests has allowed us to detect 84% of patients 
with a specificity of94%. These performances were lower for patients 
who were infected by other yeasts (C. krusei, C. parapsilosis, C. 
psmuforropicalis); sensitivity and specificity of combined tests were 31% 
and 98%, respectively 
Conclusions: This study, which clearly demonstrates a comple- 
mentation between circulation o fa  given mannan catabolite and anti- 
inaniian antibody response, suggests that use of both EIA tests may 
be helpful in routine diagnosis of candidiasis, particularly when 
caused by the most pathogenic species C. nlbirans, C. glabrata, and C. 
tropicalis. 
(p11611 Regulatory effect of fibronectin on the 
morphogenesis of Candida albicans 
Germ tube formation by Candida alhirans IS believed to play an 
important role in the initial phase of tissue invasion by promoting 
adhesion to epithelial cells. Microbial ability to bind to  fibroricctm 
(Fn) is considered a pathogenicity factor, by thlitating adhecion to 
niucosal surfaces. 
We decided to evaluate on 14 clinical isolates of C. albiiarts: (1) the 
effect of serial concentrations (15-150 pg/mL) of Fn (whole mole- 
cule and fragiiients of 120 and 70 kDa) on morphogenw\, in RI'MI 
medium; (2) the binding of "51-Fn to Cnndida with and without 
germ tubes, at different pH values. The specificity of binding was 
tested by competitive inhibition assays with unlabeled Fn. Fn (a dinier 
of 440 kDa) showed a significant dose-dependent inhibitory effect 
on germ tube formation by C. albicans (up to 96.7'X). This effect was 
pH-independent. None of the Fn fragments showed inhibition of 
geriii tube formatioti. All tested strains bound to Fn, significantly 
more after producing germ tubes (p<O.Ol), at pH 7.2. Binding 
should be considered specific because it was inhibited by uidabeled 
Fn. An increase of binding capacity paralleled the decrease in pH; the 
increased binding at lower pH values could result from noii-specific 
charge interactions taking place at a pH value below the isoelectric 
point of Fn, but a substantial part of the binding is still 5pecific. Fn 
is one of the subxtances that can explain the poor ability of C. nlbi- 
c a m  to form germ tubes in plasma, in contrast to serum. Conversely, 
at a niucosal level, particularly at low pH, as, for example, in the 
vagina and after germ tube fortnation, it may help in yeast adhesion 
and promote fungal invasion. Our results point to an important regu- 
latory effect that Fn may have upon morphologic and pathogenic 
behavior of C. albicarrs in vivo. 
Ip11621 Germ tube formation by Candida changes cell 
surface hydrophobicity 
A.G. Rodrigues',', C. Pina-Vaz',', P-A. Mirdh3, J. Martinez-de- 
Oliveira4, A.E Fonrcca'. 'Departnzent c!f~t'fiirobi@/o~qy, Porfo Srlrool of 
Medicine, zIPATIM71p(lr~st~r~re I$ P a t l ~ ~ l ~ ~ ~ q y  a d  . M ~ / m l ~ r  l n t i t ~ i t t ~ ~ ~ / ~ , q y  
.f Porto Universify), Porto, Por fup l ;  -'Cerrrerfor STD Rcienrilr, llppsnlu 
llniversify, Uppsala, Sweden; 'Departtneift oj' Gytrec(~logy, Pwto Sihool uf' 
Lbfedicincz, Portu, Portrqal 
Germ tube formation by Candida allrimis has been repeatedly related 
to an increased pathogenic capability of the n~icroorganisni. 
Adherence to liquid hydrocarbons, in particular 11-hcxadecane, is 
considered an indirect method to assess nucrobial cell surface 
hydrophobicity (CSH). Hydrophobic interactions are gcncrally 
considered to have an important role in the adherence of pathogenic 
microorganisms to host cell or foreign surfaces, 11ainely plstic. Using 
a modified microbial adhesion assay to n-hexadecane (Van der Mei 
HC, Cowan MM, Busscher HJ. Physio-chemical and structural stud- 
ies on Aiinctobacfcr calcoaccfiins RAG-1 and MK-481. Two standard 
strains in hydrophobicity tests. Curr Microbiol 23: 1991; 337-41). 
the CSH of 68 Caiidida albicaans and 30 non-albiiaws strains (5 C. 
glabrafa, 8 C. krrrsei, 5 C. tropicalis, 3 C. ,quillermondii, 5 C. parapsilusis, 
2 C. kcf'yr aiid 2 C. rngosa) were evaluated in relation to age of the 
culture (1, 2, 3 aiid i days), source of d a t e  (vagina, rectum, blood 
and bronchial secretions) and rate of germ tube formation. 
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Taken in general, species recovered from mucosal sudaces were 
mainly hydrophilic, suggesting the unimportance of CSH in the 
colonization of those epithelia. Independently of the source of isola- 
tion or age of the culture, C. albicans blastoconidia showed low 
hydrophobicity. The overall CSH of non-albicans strains was higher, 
a fact that may be evoked to help to explain the higher rates of fungal 
colonization and infection by non-albicans strains in transplanted 
patients and patients admitted to intensive care units, frequently carri- 
ers of plastic or similar foreign bodies. Increasing rates of tube forma- 
tion both in albicans and non-albiranr strains were always associated 
with significant rises of CSH, rate-related, suggesting an increased 
pathogenic role inherent in this morphologic behavior. 
[p11631 Application of the ATB System for 
identification and antimycotic sensitivity of 
Candida spp. isolated from infected children 
B. Garczewska, M. Dabkowska, D. Dzierzanowska. Department of 
Clinical Microbiology, Children 's Memorial Health Institute, Warsau: 
Poland 
Objectives: Development of the ATB System for identification and 
determination of sensitivity to antimycotics of fungal clinical isolates 
obtained from hospitalized children (1995-97). 
Methods: Clinical specimens were cultured on Saburaud medium 
and incubated at 37OC for 24-48 h. Isolated strains were identified 
to species level by use of the ID 32 C system (bioMerieux) as well as 
molecular methods (PCR). Sensitivity to antifungal agents-ampho- 
tericin B, nystatin, 5-fluorocytosine, miconazole, econazole and 
ketoconazole-was determined by use of ATB FUNGUS (bio- 
Merieux) . 
Results: A total of 483 strains of Candida sp. were isolated from 
clinical specimens obtained from children with high risk of fungal 
infections. Out of 483 strains, 418 were identified as C. albicans. All 
of them were sensitive to amphotericin B and nystatin, 92% were 
sensitive to 5-fluorocytosine, 90% to ketoconazole and 89% to 
miconazole and econazole. Systemic fungal infections in hospitalized 
children were observed in 0.5-7.1%, depending on clinical ward. In 
1996, fungemia appeared in 8 children. The number of fungemic 
children increased to 16 in 1997, and six ofthem were treated in the 
Oncology Unit. 
Conclusions: The ATB is convenient and useful for identifica- 
tion and sensitivity testing of clinical isolates of Candida spp. 
Reduction of adherence of Candida strains by 
different HIV proteinase inhibitors 
M. Borg-von Zepelin, I. Meyer, D. Sanglard, M. Monod. 
Department of Medical Microbiology, Institute of Hygiene, Gijttingen, 
Gcrmarty 
Severe forms of oropharyngeal candidiasis due to Candida albicans are 
frequently seen in AIDS patients. However, since the introduction of 
combination therapy using HIV aspartic proteinase inhibitors, their 
incidence has declined. Aspartic proteinases secreted by Candida albi- 
carts (Sap) are considered to be pathogenicity factors involved 
in adherence. These Candida proteinases have similarities with the 
HIV aspartic proteinases. The effects of four different HIV aspartic 
proteinase inhibitors, namely, ritonavir, saqninavir, indinavir and 
nefilnavir, on the activity of different C. albicans Saps were investi- 
gated using an assay based on resorufin-labeled casein as substrate. 
Three different Saps involved in adherence of C. albicans Sapl, Sap2 
and Sap3 were inhibited by these HIV therapeutic agents. As a conse- 
quence of these results, we used the HIV inhibitors to see whether 
they were able to reduce adherence of Candida cells to epithelial cells, 
an assay previously described by Borg-von Zepelin and Wagner 
(1995). Under the chosen experimental conditions we could demon- 
strate a dose-dependent inhibition of adherence of C. albirans 
SC5314 by saquinavir and ritonavir. This inhibition of adherence 
could be seen also with nine further C. albicans strains, either strains 
of different type culture collections or clinical isolates. The HIV 
inhibitors had no effect on  the Candida vitality. With immunofluo- 
rescence tests using specific anti-Sap 1 to 3 antibodies, we could addi- 
tionally demonstrate a direct influence on the Sap expression on the 
surface of Candida cells by the HIV inhibitors. We conclude that a 
direct Sap inhibition by aspartic proteinase inhibitors could 
contribute to the markedly reduced incidence of oropharyngeal 
candidiasis observed in individuals receiving anti-HIV combination 
therapy. 
Ip1165] The serum level of specific antibody to 
Candida albicans in women with recurrent 
vulvovaginal candidiasis (RWC) and in 
healthy individuals 
U. Nawrot, K. Grzybek-Hryncewicz, W. Smogor. Department of 
Microbiolou, Medical University of Wroclaw, Wroclaw, Poland 
Objectives: C. aibiuns is a common human commensal which 
becomes an opportunistic agent of superficial or deep-seated diseases. 
The objective of this work was to compare the serum levels ofspecific 
anti-Candida albicans IgG, lgA, and IgE found in women with RVVC 
and in normal controls. 
Methods: The antibody titer was investigated in serum samples 
of 37 women with R W C  and 24 healthy controls by we of the 
immunoenzymatic test. 
Results: High levels (30 U/mL) of anti-candidal IgG were 
detected in 31 (93%) of 33 patients with C. albicans vaginal infections 
but in neither of 4 patients infected by other Candida species (C. 
famata, C. glabrata, C. krusci). Specific IgA immunoglobulins were 
observed only in 12 (39%) C. albicans-infected patients. In the control 
group there were 12 (50"h) women with high IgG and 4 (17%) with 
high 1gA serum levels. IgE anti-C. albicans were not detected in serum 
samples of any patients or in the control group. 
Conclusions: The frequency of specific antifungal antibody in 
serum of women with RVVC is higher than in controls. Most 
women with C. albicans RWC (93%) and only 50% of controls 
expressed anti-candidal IgG in sera. The specific IgAs are found rarely, 
only in 39% patients and 17% controls. 
Ip11661 Evaluation of the Albicans ID2 Medium for 
rapid identification of C. albicans in clinical 
samples 
E. Amor, A. del Val, R. Blazquez, E. Leon, J. Arellano, V Mateos. 
Departinenf of Microbiolqy, Hospital de Mostoles, Madrid, Spain 
Objectives: To compare Albicans ID2 agar plates with the germ- 
tube test, used routinely in our laboratory for the preliminary iden- 
tification of yeast strains. 
Methods: A total of 125 yeast and yeast-like organisms belong- 
ing to the genera Candida, Cryptococcus, Trichosporon, Saccharomyces and 
Rhodotomla were identified. Fifty-seven (57) strains were stored clin- 
ical isolates and 68 were consecutive strains isolated from various clin- 
ical specimens using the Albicans ID2 (Bio-Merieux, France) plate 
as primary isolation medium. C. albicans ATCC 90028 and C. para- 
psilosis ATCC 900 18 were used as control strains. All strains were 
identified by API 20 C AUX and ATB ID 32 C (Bio-Merieux). The 
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germ-tube tests were performed with rabbit plarina coagulase (Difco) 
and observed after 3 h of incubation at 37°C. C. albicans ID2 plates 
were incubated at 37°C: for 48 h and examined for their ability to 
develop blue colonies. Statistical analysis was done using the Epi-Info 
program. 
Results: Blue colonies in Albicans ID2 plates were produced by 
all the C. albirans and 4 of 1 ;I (36%) C. tropicalis strains. The sensi- 
tivity (S), specificity (SP), po:itive predictive value (PPV) and nega- 
tive predictive value (NPV) were 100%, 94.3%, 3.2% and 100% 
respectively. Six (1  1 %) C. alhirans and four (36%) C. tropirali.c strains 
were incorrectly identified with the germ-tube test, showing S, SP, 
PPV and NPV of 89.1%, 94.3%, 98% and 92% respectively. 
Comparison of sensitivities yields a statistically significant difference 
(p<= 0.03). 
Conclusions: Compared with germ-tube, Albicans ID2 plates 
have better sensitivity and similar specificity in the identification of 
C. albicutrs strains. It is a method that is easy to use, simple to read 
and very suitable for routine use in clinical laboratory settings, avoid- 
ing additional timeconsuminp tests. 
/p1167) Cultural-mycologic findings in esophageal 
candidosis 
K. Zn~iinerniai~n~,  H.  Uernhxdt', U. Hecker', M. Knoke', J. 
Uernhardt', K.  Schulz'. 'Clii~i'c of Interrzal Medicine A ,  'Clinic q/ 
Sicqery, Uiriuersify 4 Gre$Jsumld, Greijfsuiald, Germany 
Objectives: We evaluated positive cultural-mycologic finding of 
esophageal brushing from patients with infected esophagi and 
compared these results with mycologic findings of additionally inves- 
tigated materials. 
Methods: I n  esophageal brushing from 90 patients undergoing 
endoscopy of the upper digestive tract, yeasts were found. All patients 
had visible niycotic areas. Frcmi 43 patients, other materials of the 
digestive tract (swabs of oral rriucosa, feces, swabs of the anal region) 
were investigated in addition, and these results were compared with 
those of esophageal cultures. 
Results: From esophageal brushing, yeasts were isolated in 72% 
(65/90) in nionoculture and in 28% (25/90) in mixed cultures. 
Catidida albiiaris was the most commonly isolated species (63Xmono- 
culture, 24Xmixed culture), followed by C. glabrata and C. fropicalk. 
We found identical cultural results in 56% (24/43) in esophageal find- 
ings in comparison to those of the additionally investigated materi- 
als. There were divergent findings between esophageal samples and 
other rnaterials in 44% (19/43:8. In a few cases (3143, 7%), the esoph- 
agus was the only site where yeasts were found. Other spectra of 
species of esophagus than those of oral swabs or feces/anal swabs were 
proven in 26% (1 1/43). Comparing culture results of the esophagus 
with those of the oral cavity yielded identical results in 69%. In 
fecedanal swabs, only 47% wme identical. 
Conclusions: In esophageal candidosis, C. albicans was the most 
commonly isolated pathogen. Mycologic findings of esophageal 
brushiiigs correlated more often with results from the oral cavity than 
with those of fecedanal swabs. 
Ip11681 Susceptibility of Candida parapsiiosis to 
antifungal agents 
E. Cantbn', J. Peniin', A. Cai-rillo-Mufioz', P Ubeda', M. 
Gobernado'. 'Centro de Itzvest[@h, 'Servicio de Mirrohiologia, 
Hospifal liniv. La Fe, Valencia, Spain 
Objectives: To evaluate and compare by three methods the suscep- 
tibility to itraconaeole (IZ), fluconazole (FZ), and amphotericin B 
(AMU) of 37 strains of Candida parapsihis isolated from the blood- 
stream. 
Methods: M27A macrodilution method (NCCLS), a modified 
macrodilution method with 2% glucose (M27A+g), and agar diffu- 
sion method (NeoSensitabs). 
Results: MICs were lower in M27A+g, especially for AMB. The 
MICcws in M27A/M27A+g were: 0.25/0.12 for IZ, 8/8 for FZ, and 
0.2W0.5 for AMB. The G mean MICs in M27A/M27A+g were: 
1.12/1.02 for FZ, 0.02/0.02 for IZ, and 0.22/0.13 for AMB. The 
agreement between the two macrodilution methods (-2 log) were: 
91.8% for IZ, and 97.2% FZ and AMB. The diffusion method 
misclassified 7 strains for FZ, and 4 for 12. 
Conclusions: MICs are equivalent by the two macrodilution 
methods, with the advantage that MICs can be determined at 24 h 
by the M27A+g method. N o  correlation was found between MICs 
and inhibition zones. We recommend the determination of MIC for 
all strains that prove resistant to FZ by the diffusion method. 
Effects of macrophage colony-stimulating 
factor (M-CSF) on antifungal activity of 
neonatal monocytes against Candida aibicans 
E. Koilides, E. Gioulekas, M. Goutzioulis, S .  Tsaparidou, C .  
Pharmakis, V Drossou, G. Kremenopoulos, J. Tsiouris. Dcpartnients 
oj Pediafrirs, Obstetrin/C;ynerolo~~y and N~onatolo~qy, Uniuerriry of 
Thrssaioriiki, ?'hessa/oniki, Greere 
Objectives: To compare the effects of recombinant human M-CSF 
on antifungal activities of monocytes (MNCs) from neonates and 
adults against C. al6icans. 
Methods: MNCs were prepared from blood derived from 18 
umbilical cords, 8 healthy full-term neonates (1-3 days after birth) 
and 14 healthy young adults by Ficoll centrifugation and adherence. 
Then, MNCs were incubated with 0.15-15 ng/mL M-CSF for 2-3 
days. 
Results: Both umbilical cord and postnatal MNCs exhibited anti- 
fungal activities assessed as phagocytosis of serum-opsonized blasto- 
conidia of C. albicans and snperoxide anion ( C P )  production in 
response to either PMA or serum-opsonized blastoconidia similar to 
that of MNCs from adults. No functional differences were detected 
between the two sources of neonatal MNCs. Fifteen ng/niL M-CSF 
enhanced 0'- production by MNCs from both adults (1.61 20.22 
iimol 0'-/1(1" MNCs as compared to 0.82F0.18 of controls, 
p=0.004) and neonates (1.46?0.21 as compared to 0.86+-0.19 of 
controls, p=0.004) in response to PMA. In addition, M-CSF 
enhanced 0'- production by MNCs from adults in response to 
opsonized blastoconidia (1.49*0.13 nmol 0 ' - /1O6 MNCs as 
compared to 0.88+-0.16 for controls, p=0.03), but it did not affect 
0'- production by neonatal MNCs in response to the same stimu- 
lus. Similarly, M-CSF significantly enhanced phagocytic activity of 
adult MNCs (phagocytic index was 2.52k0.23 as compared to 
2.06k0.1 for controls, p=0.03) but not of neonatal MNCs. 
Conclusions: M-CSF enhances phagocytic and oxidative anti- 
fungal activities of adult MNCs against C. albicans, but it exerts only 
limited enhancing effects on the anticandidal function of neonatal 
MNCs. 
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In vitro activity of voriconazole against 
clinical isolates of Candida and Aspergillus in 
comparison with other antifungal agents 
C. Wallrauch, D. Milatovic, I. Braveny. Institute oJMedical 
Microbioloa, Technical University $Munich, Munich, Germany 
The in vitro activity ofvoriconazole (vori) against 153 clinical isolates 
of Candida was compared to that of amphotericin B (ampho) and 
fluconazole (fluco). Against Aspergillus fumigatus (asp. fum) isolates, 
the activity of vori was compared to that of ampho and itraconazole 
(itra). The following isolates were tested C. albicans (C. alb.), C. trop- 
icalis (C. trop.), C. glabrata (C. glab.), C .  kmsei (C. krus.), C. parap- 
silosis (C. para.), C. noruefensir (C. nor.) and Candida spp. (C. famata,  
C. lusitaniae, C. guilliermondii, C. kefrr) as well as 11 asp. fum. 
The minimal inhibitory concentrations (MICs) were determined 
using the broth microdilution method according to the M27P proto- 
col of the NCCLS. The minimal fungicidal concentrations (MFCs) 
were determined by plating 10-pL samples on Sabouraud agar from 
those wells in which fungal growth appeared to be inhibited; after 
incubation, the MFCs were recorded as the lowest concentration to 
yield no colonies. 
C.alb. C.glab. C.e,”‘%.%? C.para C.nor. i.zpg 
n-47 n-30 n-3? n=17 n = 1 5  n = 5  
VOri 0.5 0.25 60.06 0.25 50.06 0.5 60.06 
Fluco 32 4 1 16 1 32 4 
Ampho 2 2 2 2 1 2 2  
Vori showed very good activity against all Candida species, including 
C. krus. and 12 fluconazole-resistant strains of C. alb. (MICw: 0.5 
mg/L). It exhibited fungicidal activity against C. para. and C. krus. 
with MFCs of 8 mg/L and 32 mg/L respectively. Against asp. fum. 
the M I G O  was 0.25 mg/L, and therefore lower than that of ampho 
and itra. Fungicidal activity was also observed against asp. fum., with 
an MFCW of 16 mg/L 
v1 Improvement of testing of fluconazole (FCA), 
voriconazole (VOR) and itraconazole (ITR) by 
modification of recommended media for 
yeast susceptibility testing 
A.F. Schmalreck, I. Kottmann, A. Reiser, P. Trankle, E. Vanca. 
Department $Microbiology, Heinrich Mack Nachfolger, Illerrissen, 
Germany 
Objectives: To improve testing of yeasts by improvement of growth 
properties, endpoint readability, and reproducibility of susceptibility 
test culture media. 
Methods: For 378 isolates, minimum inhibitory concentrations 
(MIC) were determined by microdilution and Etest, and inhibition 
zone diameters (IZD) by agar diffusion. RPMI 1610, H R  or 
Mueller-Hinton (MH) were supplemented with 2% glucose (final 
concentration) and 0.5 mg methylene blue/L (MB), and H R  
medium in addition with 1 g asparagine/L. Sodium bicarbonate was 
not used in any media. Instead of MOPS buffer, 0.05 M phosphate 
buffer (final concentration) was used in all media, except MH 
medium (no buffer supplement). 
Results: With 2% glucose, sufficient carbohydrate is available to 
provide growth for all clinically significant yeasts. Deletion of bicar- 
bonate results in less medium change during incubation and no 
medium precipitates during preparation and storage. Use of phos- 
phate instead of MOPS buffer resulted in less growth inhibition of 
several clinical isolates. Although a few isolates demonstrated delayed 
growth with MB, methylene blue improved significantly the read- 
ability (sharp inhibition zones, no trailing, definitive endpoints) with 
all of the culture media. In addition, tests ofslow-growing yeasts such 
as Candida glabrata could be read within 24 h. Spearman correlation 
coefficients (r) of MICs with the different culture media and percent- 
ages (%) of the antimycotic (AM) MICs which are within 2 2  MICs 
were: 
Conclusions: RPMI and H R  medium give similar results with MB 
supplementation and improve with MB reading of MIC and IZD 
endpoints significantly. MH without supplementation is not suitable 
for MIC or IZD susceptibility tests. These preliminary results should 
be confirmed by a larger data set within a collaborative study. 
Effect of antifungal agents on Candida spp. 
and fichia anornala isolates from 
oropharyngeal candidiasis of AIDS patients 
M.L.M. Branchini, EH. Aoki, F! Papaiordanou, A.L. Colombo, H. 
Taguchi, K. Yamamoto, M. Miyagi. Infctious Diseases Division, 
Universidade de Campinas, Universidade Federal de Sao Paulo, Brazil; 
Chiba University, Japan 
Objectives: In order to determine the clinical significance of 
oropharyngeal candidiasis in AIDS patients, 44 isolates collected from 
individual clinical episodes were evaluated. 
Methods: The isolates were identified by microbiological stan- 
dard methods, and in vitro antifungal susceptibility testing was eval- 
uated for amphotericin B, fluconazole, flucytosine, miconazole, 
itraconazole and ketoconazole according to the National Committee 
for Clinical Laboratory Standards. Candida albicanr ATCC 90028 was 
used as control for the MICs. The microbiological isolation revealed 
two strains as Pichia anomala, an uncommon pathogen in AIDS 
patients. 
Results: C. albicans and Candida tropicalis comprised 35 and 6 
isolates, respectively. 2 isolates were identified as Pichia anomala and 
1 strain as T glabrata. The antifungal susceptibility testing for C. albi- 
cans isolates revealed low sensitivity, and 19 strains were resistant to at 
least one antifungal agent. All C. tropicalis isolates were resistant to 
flluconazole and miconazole. 
Conclusions: The resistant profiles of these Candida spp. are of 
major concern once fulconazole is not commonly prescribed for the 
treatment of oral candidiasis in our AIDS patients. The local diver- 
sity of species and the variability of MICs and ICm in antifungal 
agents presented in this study lead to a clinical and laboratory contin- 
uing evaluation of oral candidiasis in our HIV-1 patients. 
Detection of antigen galactomannan of 
Aspergillus in the urine of patients with lung 
disease 
E. Anastasakou, C. Kapotis, E. Kosmaoglou, S. Triantafillou, E. 
Marinis. Department .f Microbiology, Sotiria Hospitalfor Chest Diseases, 
Athens, Greece 
Objectives: To detect Aspergillus antigen galactomannanin in urine 
of non-immunocompromised patients with lung disease and to 
compare the results of this method with Aspergillus antibody detec- 
tion in the serum of these patients by the classic ELISA assay. 
Methods: 47 patients, 25 of them with known active aspergillo- 
sis and 22 controls, were included in the study. From every patient 
we collected urine for the detection of galactomannan antigen and 
A b s t r a c t s  40 1 
serum for the detection of Aspegillus antibodies IgG, IgM, and 1gA. 
Both tests were done with the ELISA method. 
Results: Among the 25 pacients with aspergillosis, 19 were posi- 
tive in both tests. O f  the rest, 6 out of 25, 5 were positive for the 
galactomannan antigen in the urine but were negative for serum anti- 
bodies, and 1 was positive for serum antibodies without having the 
galactomannan antigen in the urine. None of the 22 controls had 
positive results in either one of the tests. 
Conclusions: The results of our study suggest that detection of 
Aspexillus antigen galactomannan in the urine is a more sensitive 
method than the detection of IgM Aspeyillus antibodies in the serum 
with the classic ELISA assay. Although there are not yet sufficient data 
in the literature, it seems that the combination of the two methods 
increases the sensitivity and minimizes the rates of no identification 
of Aspergillus. 
ml Evaluation of the Etest method with 
microdilution broth for determining 
susceptibilities of 40 clinical Aspergillus 
isolates 
A. Valverde, M.C. Serrano, M. Chivez, S. Bernal, E. Martin- 
Mazuelos. Departnient cf S. MicrobioloxN Hospital Hdrne, Seville, Spain 
Objectives: To compare the Etest method with the reference 
method (microdilution broth, MDB) to study the 'in vitro' suscep- 
tibilities of AsperXillus sp. to three antifungal agents. 
Materials and methods: 40 clinical Aspergillus sp. Isolates were 
selected for testing (A. glaucus 21, A.fumigatus 15, A .  niger3, A .  terreus 
1). The Etest method was performed according to the manufacturer's 
instructions. MDB was performed according to NCCLS document 
M38-P. The antifungal agents assayed were: amphotericin B (A), itra- 
conazole (I) and 5-flucytosine (5FC). 
Results: .'In vitro' activity of A, I and 5FC against 40 Aspe<gillus 
sp. by both methods: 
0.01 YO.  12 
O.IU05 
>64 76.9 
Conclusions: (1) High MICs of 5FC to all strains studied. (2) MIC 
values higher by Etest than by MDB. (3) Low percentage of agree- 
ment between both methods. (4) A .  fui.m&atus and 5FC showed the 
best correlation. 
m1 Hospital water supply as a potential source 
of nosocomial opportunistic mold infections 
P. Venveij', J. Meis', M. van dlen Bergh', B. de Pauw2, A. Voss'. 
'Department of Medical Microbiology, 'Department o f  Hematology, 
University Hospital Nijrnqen, Akjmepz, T h e  Netherlands 
Objectives: To determine the level of contamination of hospital 
water supplies with opportunistic molds in a hematology ward and 
to compare the results with molds involved in fungal disease in that 
department over the past 5 years. 
Methods: All water outlets, drainage pipes and showerheads from 
the hematology ward were cultured for the presence of molds. At all 
sites, specimens were obtained by swabs which were streaked onto 
Sabouraud glucose agar plates containing 10% chloramphenicol and 
gentaniicin. Plates were incubated at 35°C for 96 h and examined for 
the presence of fungi every :!4 h. Molds were identified by their 
colony characteristics and the appearance of their conidia and coni- 
diophores. The database ofthe Department of Medicdl MicrohioloLy 
was searched for fungi which had caused fungal disea\e arnong 
patients cared for in the hematology department. 
Results: Molds were recovered from any water source in 6 of 1 1  
(55%) patient rooms and from outlets in rooms occupied by health- 
care workers. Furthermore, the showerhead of a shower used by 
patients cared for in rooms without washing facilities was also posi- 
tive. Firsariurn species were the most prevalent, followed by 
Cladosporiurn species. Aspetgillus species were not recovered from any 
of the cultured sites. The prevalence of invasive aspergillosis was 6% 
in the hematology ward over the past 5 years and infections had been 
caused almost exclusively by Aspergillnsfurnigatus. Other molds had 
caused infection only sporadically and no cases of invasive mfectioiis 
by Fusarium or Cladosporium species were identified. 
Conclusions: Opportunistic molds may be present in the hospi- 
tal water supply, but in our hospital, water appeared not to be a major 
factor in the transmission of invasive fungal infections. 
I P I  176 I lnvasive aspergillosis caused by Aspergillus 
usfus: case report and review of the literature 
P, Verweij'. M. van den Bergh', P. Rath', U. de Pauw', A. Voss', 
J. Meis'. 'Department of Medical Microbiology, ZDPpartnierzl q. 
Hematology, University Hospital Nijrnegen, Nijmegen, 'I7re Netkerlarrds; 
'Institutfur Medi.ziiuscke Mikrobiolozie, Universitat-C;H Esscn, Esseti, 
Gerniany 
Objectives: To describe invasive aspergillosis by Aspc,@lkrs iistiis in 
a hone niarrow transplant (BMT) recipient and conipare it with those 
described in the literature and to determine the in vitro activity of 
aniphotericin B (AB), itraconazole (ITZ), voriconazole (VCZ) and 
terbinafine (TB) against 12 clinical and environniental A.  irstirs 
isolates. 
Methods: The MIC was determined by a broth microdilution 
method according to the proposed standardized pi-occdure for anti- 
fungal susceptibility testing by the NCCLS. Each drug was two-fold 
diluted to obtain concentrations ranging from 64 to 0.06 iiig/L. The 
plates were incubated at 37°C and read after 24 and 48 h of incuba- 
tion. For AB, the MIC endpoint was defined as complete inhibition 
of visible growth, and for T B  and the azoles, 75% growth inhibition 
compared with control wells. Subcultures from the wells with the 
lowest drug concentrations showing 99.9% reduction from the orig- 
inal inoculum size were judged to contain the minimal fungicidal 
concentration (MFC). The literature for the years 1960-98 cvas 
reviewed for case reports of invasive aspergillosis caused by A.  usfus. 
Results: The patient received a BMT from a matched unrelntcd 
donor. He developed pulmonary infiltrates during treatment with 
high-dose corticosteroids for graft-versus-host diqease and broad- 
spectrum antibacterial agents, but showed no response to AB and 
died. A .  ustus was recovered from lung tissue cultures obtained at 
autopsy Six cases of invasive aspergillosis caused by A iistiis havc becii 
described previously, including 3 which involved infection of the skin 
after it had been occluded. Indeed, we also recovered A .  tistus from 
the hematology ward shortly after the patient had died, which may 
suggest a nosocomial origin of infection. ITZ and VCZ chowed 
fungistatic activity but both AB and TB were fungicidal, with T U  
showing the greatest activity. 
Conclusions: Invasive infections by A. ustus are uiiconmioti but 
may be nosoconiial in origin. T B  appears to have the greatest activ- 
ity in vitro. 
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I P ? ]  In vitro antifungal activity of Nyotran 
(liposomal nystatin) against opportunistic 
filamentous fungi 
A.J. Carrillo-Mufioz', l? Arevalo2, G. Quind69, V Rodriguez4, 
0. del Valle4, A. del Palacio5, J. Pemin', E. Cant6n7, J.M. 
Hernindez-Molina8, l? Santos', T. Wallace"'. 'ACIA, Barcelona, 
'University de ta Laguna, h e r + ,  'University Pa& Vasco, Bilbao, 
4Hospital Val1 d'Hebron, Barcelona, 'Hospital 12 Octubre, Madrid, 
6Hospital University la Fe, Valencia, 'Hospital Severo Ochoa, Madrid, 
'Hospital La Inmaculada, Hutrcal-Overa, Almeda, Spain; 'Hospital 
Pablo Garrahan, Buenos Aires, Ayentina; "'ARONEX Pharmaceuticals, 
Texas, USA 
Objectives: To compare the in vitro antifungal activities of a new 
nystatin liposomal formulation (NYO), ny5tatin ( N Y S ) ,  ampho- 
tericin B (AMB), liposomal amphotericin B (LAB), amphotericin B 
lipid complex (ABLC), amphotericin B cholesteryl sulfate complex 
(ABCD), fluconazole (FLZ) and itraconazole (ITZ) against 100 
isolates of clinically important filamentous fungi. 
Methods: MICs were determined by the microdilution method 
in RPMI 1640 according to Espinel-Ingroff et a1 fJ Clin Microbiol 
1997; 35:139). Isolates included 62 Aspergillus spp., 9 S. prol$cans, 8 
Fusarium spp., 8 I? boydii, 1 Cephalosporium sp., 1 Phialemonium sp., 1 
A. rorymbijra, 1 E. jeanselmeni, 1 A. tenuissima, 1 Myceliophtora sp., 3 
M.  cartis, and 2 7: mentagrophytes. 
Results: The overall geometric means were NYO 4.09 pg/mL, 
ABLC 4.33 pg/mL, AMB 1.97 pg/mL, ABCD 3.2 pg/mL, LAB 
5.53 pg/mL, NYS 5.67 pg/niL, FLZ 201 pg/mL, and ITZ 1.03 
pg/niL. The in vitro antifungal activity of NYO was higher than the 
efficacies of ABCL, LAB and ABCD for Aspegillus spp. (MICro 2-4 
pg/mL versus 16 pg/mL, respectively). NYO MICs were much lower 
than those of FLZ. Fusarium spp. strains were especially susceptible 
to NYO (MIC9o 2 pg/mL). MICs for I? boydii were 16 pg/mL for 
ABLC, LAB and ABCD, while NYO had an MIC of 8 pg/mL. NYO 
activity against I? boydii was higher than that of ITZ. 
Conclusions: NYO had an excellent in vitro antifungal activity 
against most of the clinically relevant filamentous fungi studied. The 
results suggest, support growing clinical evidence, that this nystatin 
liposomic formulation (NYO) could be an effective therapeutic aid 
for the treatment of opportunistic mycoses. 
[m Opportunistic fungal pathogens in 
biocontainers: a potential health risk to 
immunocompromised patients? 
P. Verweij', A. Rijs', J. Donnelly', B. de Pauw', J. Meis'. 
'Department of Medical Microbiology, ZDepartment of Hematology, 
University Hospital Nijmqen, Nijmegen, The Netherlands 
Objectives: To establish the exposure to opportunistic fungi in 
biocontainers used for storage of household organic waste. 
Methods: The risk of exposure to a cloud of spores which may 
be released during opening of the lid of the biocontainer was inves- 
tigated by culturing 50 biocontainers before they had been emptied 
and another 54 afterwards. Sabouraud glucose plates containing 10% 
chloramphenicol were exposed directly to the air flow while open- 
ing and closing the lids. The plates were incubated a t  35°C and exam- 
ined for the presence of fungi, which were identified by their colony 
characteristics and the appearance of their conidia and conidiophores. 
Results: Before emptying, 34 of 50 (68%) biocontainers were 
culture positive for fungi and in 15 (30%) opportunistic molds were 
present, while after emptying, only 23 of 54 (43%) were culture posi- 
tive (p<0.01). However, 11 (20%) biocontainers remained positive 
with opportunistic molds even after they had been emptied. 
Aspe@us species were cultured from 12% of biocontainers before 
emptying and from 15% afterwards. 
Conclusions: Clouds of opportunistic fungi, including Aspergillus 
species, are released from biocontainers during opening and closing 
of the lids. Although during hospitalization every effort is made to 
reduce exposure of immunocompromised patients to fungal spores, 
these patients often remain susceptible to infection after discharge. 
Thus, it seems prudent for them to avoid biocontainers completely, 
at least until the risk of infection can be quantified. 
Typing of Pneumocystis cariniif. sp. hominis 
by PCR-single-strand conformation 
polymorphism: evidence of co-infections and 
identification of the co-infecting types 
Ainiable Nahimana , P. Francioli, P.M. Hauser, J. Bille, D.S. Blanc, 
C H U V  Hospital, Hospital Preventive Medicine, 
The typing method for Pneumocyrtis carinii f. sp. hominis consisting of 
PCR-single-strand conformation polymorphism (SSCP) analysis of 
four genomic regions was tested on bronchoalveolar lavage specimens 
(BALs) from I? carinii pneumonia patients. Thirty-five per cent of the 
BALs produced only simple SSCP patterns made up of a single allele 
of the genomic region, suggesting an infection with a single Pc. 
hominis type. Each combination of four simple patterns corres- 
ponding to the four genomic regions defined a type. The rest of the 
specimens displayed at least one complex SSCP pattern made up of 
two simple patterns, suggesting three theoretical possibilities: co- 
infections, heterozygosity, or multicopy genes. The different simple 
patterns composing the complex SSCP patterns were most often 
present in different proportions, suggesting co-infections with two 
PC. hominis types, rather than heterozygosity or multicopy genes, 
which would have implied identical proportions of the alleles. This 
interpretation was confirmed by the analysis of mixtures of specimens 
producing different simple patterns which demonstrated that PCR- 
SSCP analysis detects the variation of the proportions of the alleles 
in a mixture. Quantification of the simple patterns in the complex 
patterns produced by single specimens showed that the proportions 
of the two co-infecting types varied from specimen to specimen. 
Because of their different abundance, the co-infecting types could be 
identified in the majority of the co-infected specimens, greatly 
improving the usefulness of the multi-target PCR-SSCP method for 
the study of I?(. hominis epidemiology 
Etest susceptibility testing to fluconazole of 
C. neoformans. correlation with clinical 
outcome 
A.I. AIler', E. Martin-Mazuelos', E Lozano2, M.J. Gutierrez', J. 
G6mez-Mateos'. '5'. Microbiology, 'U. In3ctious Diseases, Hospital 
Valme, Sevdle, Spain 
Objectives: To study the correlation of Etest susceptibility testing 
with clinical outcome in AIDS patients with cryptococcal infection 
(Cl) treated with fluconazole as niaintenace therapy. 
Patients and methods: We prospectively evaluated 8 episodes of 
C1 in 5 AIDS patients who developed clinical resistance to flucona- 
zole after treatment, two patients as maintenance therapy (200 
mg/day PO) and three by oropharyngeal candidiasis (100 mg/day 
PO). The absence of improvement or exacerbation of symptoms and 
clinical findings was considered to constitute clinical resistance. The 
minimal inhibitory concentrations (MICs) of fluconazole were deter- 
nuned by the Etest method following the manufacturer's guidelines. 






'Reading a t  72 h. 'Actual treatment with itraconazole (6UO ing/day 
PO). **The patient died duririg the first episode. 
Conclusions: AD the patients in the episode of clinical resistance, 
showed MIC values of 4 pg/mL. More investigations are needed to 
further assess the potential value of the Etest for antifungal suscepti- 
bility testing of C. rieoformans, especially in detecting potential resis- 
tant isolates. 
[p11801 Comparison of monoclonal and polyclonal 
antibody-based latex test for the diagnosis of 
cryptococcosis 
M. Tabouret, A. Ihtry. Sam$ Parteur, Steenimorde, France 
Objectives: To compare Pastorex Crypto Plus, an improved mono- 
clonal antibody-based test developed by Sanofi Diagnostics Pasteur, 
with the Meridian latex test (Gypto Latex Test) for the detection of 
circulating glucuronoxyloniannan from Cryptomccns in biological 
fluids. 
Methods: Sensitivities ofthe two assays were assessed in a prospec- 
tive study on 6 sera, 3 cerebrospinal fluids (CSF) and 9 urines from 
patients with cryptococcosis, and in a retrospective study testing 22 
sera and 10 CSE The specimens used for specificity analysis were 
collected from patients without signs of cryptococcosis during 
prospective (30 sera, 7 CSF, 6 urines, 21 bronchoalveolar fluid) and 
retrospective (32 sera) studies. 
Results: The sensitivity of the two assays was 100% during the 
prospective study. In the retrospective study, 8 samples were consid- 
ered as negative with the Meridian assay in spite of agglutination at 
dilution - with this assay. These results led to a sensitivity of 75% if 
we followed Meridian's recommendations and to a sensitivity of 
100%1 if we considered them a.s positive. 4 of these 8 samples were 
negative in the Pastorex Crypto Plus assay (sensitivity: 87.5%). The 
specificity of the two assays was 100% during the prospective study, 
but results of 8 samples were uninterpretable with the Meridian test. 
2 sera gave positive reactions with Pastorex Crypto Plus in the retro- 
spective study (specificity: 949.6 compared to 100% for the Crypto 
Latex Test). 
Conclusions: The two assays have comparable performance and 
allow a good diagnosis of crypi:ococcosis. 
Ip11811 Fungal sepsis in patients hospitalized at a 
tertiary care hospital 
E. Swoboda-Kopec, M. Krajecvska, B. Sulik, M. Luczak, E. 
Stelniach. Department of Bacteriolqy, Central Clinical Hospital; 
Deparfmrwt $Medical Micmbioloqy, Medical Academy, Warsaw, Poland 
Objectives: Analysis of fungal isolates as etiologic agents of sepsis in 
patients hospitalized in surgical wards, internal medicine wards and 
the intensive care unit (ICU) clf a tertiary care hospital. 
Methods: The study involved the patients hospitalized at the 
Central Clinical Hospital in Wmaw in the period 1 January 1997 to 
31 December 1997. The samples of peripheral blood from patients 
suspected of having sepsis were examined using the Bact-Alert system 
(Organon Teknika). The fungi were cultured and identified accord- 
ing to standard mycologic procedures (bioMerieux, Sanofi Pasteur). 
The sensitivity to antifungal agents was tested wing ATH Fungus 
(bioMerieux) and Fungitesr (Sanofi Pasteur) tests. 
Results: In total, 1380 blood culture samples were positive, 
including 38 fungal isolates (3% of the total number of samples). 
Among cultured fungi the following species havc bcen identified: C. 
parapsilosis 15 (39.5%), C. albicans 14 (36.9%), C. glnbrata 3 (7.9'%), C. 
melibiosica 2 (5.3944, C. tropicalis 1 (2.6%), C. pillermondir 1 (2.h%), 
C. pefliculosa 1 (2.6%), and Tvichosporon cufaneum 1 (2.6%). The isolates 
were mainly obtained froin patients in surgical wards-24 (63.2%)). 9 
isolates originated from internal medicine wards (23.7%) and 5 
isolates (13.1%) were cultured from the ICU. Among the isolates 
from surgical wards, C. parapsilosis dominated, while in the internal 
medicine wards, C. albicans dominated. An interesting finding was a 
culture of Tvicliosporon cntaneum as an etiologic agent of sepsis. 
Conclusions: (1) The most common etiologic agenti of fungal 
sepsis were Candida parapsilosis and Candida albicans. (2) Cases of 
fungal sepsis were more common in patients treated in the surgical 
wards 
Ip11821 Sporobolomyces spp. infection in a boy with 
AML case report 
M. Jandrlic, S. Kalenic, J. Jakic-Razumovic, L. Rajic, R. Ferninic- 
Kes, J. Konja. Department qf Microbiology, Za'qrcb Uniucjrsity Hospital, 
Zaxreb, Croatia 
Sporobolumyces spp. are ubiquitous in the environment, and have rarely 
been implicated in human disease. A 15-month-old boy with acute 
myelobiastic leukemia was treated with an AML-BMF 87 protocol 
and complete remission was induced after 5 courses of therapy 
During hospitalization (13 months), he had four episodes of granu- 
locytopenia with several febrile episodes, during which he was 
treated with antimicrobials. He had two episodes of candidemia, 
treated with fluorocytosine (SFC) for 37 days, and amphotericin I3 
(AFB) for 12 days. He was on antifungal prophylaxis with nystatin 
during the first 5 months. O n  day 194 of his hospitalization, during 
the fifth course of therapy (granulocyte count till 0.1 X 10"/L), he 
developed high fever (40°C); all diagnostic cultures were sterile. Two 
weeks later, the chest radiographs showed milliar pneuinonia. 
Tuberculostatics, corticosteroid and ganciclovir were added to 
imipenem, vancomycin, AFB and SFC, without any success, and 
open lung biopsy was performed on day 233. Sporobolornyns ~ p p .  and 
Carzdida albicans were cultured, and yeast with hyphae were seen on 
histology of the biopsy specimens. Tuberculostatic therapy was inter- 
rupted and liposomal AFB with 5FC started (134 days, total 3122 mg 
and 134 g) and after that fluconazole was given for 403 days (20.15 
g). He had about 40°C fever for 6 months, and then the fever grad- 
ually subsided, with a slow but total regression on chest radiographs. 
Currently he is in good condition, in first remission, and itable. 
Ip11831 Case of peritonitis caused by Paecilomyces 
variotii 
T. Zohar Cretnik', V Bozanic', A. Storman', M. Lesnik2. 
'Deparfmcnt ojMicrobiology, Institute qf Pirblii- Health, '<~enc~ral 
Hospital, Celje, Slovenia 
Objectives: Paecilomyces variorii is a rare cause ofperitonitis in patients 
on continuous ambulatory peritoneal dialysis (CAPD). We report the 
isolation of P variofii from peritoneal dialysate in a 42-year-old female 
on CAPD, which is, to our knowledge, the first in Europe. 
Case report: A 42-year-old female was started on CAPD in 
October 1994 because ofend-stage renal disease. In March 1996 she 
developed abdominal pain and cloudy peritoneal dialysir effluent 
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(PDE) which had a white cell concentration of 200/mm-. Initial 
cultures for bacteria were negative but from samples taken on three 
consecutive days at the end of April fungal growth was seen. The 
isolates were identified as I? variotii. The antifungal susceptibility test- 
ing showed resistance to fluconazole and susceptibility to ampho- 
tericin B, flucytosine, ketoconazole and itraconazole. The patient's 
condition worsened-paralytic ileus developed-in spite of removal 
of catheter and intravenous application of amphotericin 8. Because 
of aplasia, application of amphotericin was discontinued and itra- 
conazole was introduced. After 1 year of treatment with itraconazole, 
the patient was well but remained on hemodialysis. 
Methods: Samples of PDE were aseptically collected. 25-mL 
volumes of each sampie were centrifuged. From the pallet a smear 
was prepared for Gram staining. Blood agar plates, Sabouraud 
dextrose agar plates, Sabouraud broth and thioglycolate medium were 
inoculated. After incubation at 26OC, fungal growth was detected. 
The isolates were identified by macroscopic and microscopic charac- 
teristics as Paecilomyces variotii. 
Conclusions: Fungi, I? variotii among them, must be considered 
as a probable cause of peritonitis in patients on CAPD. 
WI Peritonitis caused by Streptomyces griseus in 
a patient on CAPD 
N. Cerikcioglu, A. Topkaya, €? Ciragil, S .  Kiris, V. Korten, E 
Babacan. Faculty ofkfedicine, Marmara University, Istanbul, Turkey 
A 64-year-old man with end-stage renal failure secondary to hyper- 
tensive nephrosclerosis and maintained on chronic ambulatory peri- 
toneal dialysis (CAPD) for the last 22 months presented with 
abdominal pain, cloudy effluent and malaise to the emergency 
room.On direct examination of the peritoneal fluid, the WBC count 
was 400/mm' and no organisms were seen on Gram stain. Empirical 
antibiotic therapy was started with vancomycin 2 g/week and 
amikacin 125 mg/day intraperitoneally. During this time the culture 
of the peritoneal fluid revealed very slow growth which was identi- 
fied as Sfreptomycesgriseus. On the fourth day of treatment the patient 
was admitted to the hospital since his abdominal complaints and the 
cloudy effluent persisted. Although the direct examination w a s  nega- 
tive, the culture revealed a slow-growing organism which was again 
identified as S. griseus. Going back to the history of the patient, it was 
learned that the patient performed his dialysis in a forest while he was 
taking a trip. 
Streptamyces species are organisms of the soil. According to the 
history given by the patient, the most likely source of the organism 
reported in our study was the soil. As far as we could see in the liter- 
ature, this is the second peritonitis case caused by s. griseus. 
Rapid single-step procedure for extracting 
fluconazole from plasma before measuring its 
concentration in blood by high-performance 
liquid chromatography (HPLC) 
PA. Majcherczyk, 0. Marchetti, M I ?  Glauser, J. Bille, €? 
Moreillon. Division of hfectious Diseases, CHUK Lausanne, 
Switzerland 
Introduction: Measuring drug levels in blood requires careful 
sample preparation to extract drug from plasma proteins. Most proto- 
cols use organic solvents and/or solid extraction phases. This is time- 
consuming and entails several manipulations, which can lead to loss 
of material and increased variability. Moreover, to obtain sufficient 
material for analysis, at least 1 niL of plasma is required. This 
constraint makes it difficult to determine drug kinetics in neonates 
and small animals. 
Objectives: To develop a single-step method for extracting the 
widely used antifungal azole, fluconazole, from small amounts of 
plasma, and then determine its concentration by HPLC. 
Methods: Fluconazole standards and unknowns were prepared in 
rat and human plasma. Samples (240 id,) were transferred into dispos- 
able microtube filtration units containing cellulose filters (5 kDa cut- 
om. After centrifugation for 60 min at 15 000 g. using an ordinary 
bench-top centrifuge, fluconazole concentrations were measured 
directly in the filtrate by HPLC. 
Results: Enough material was obtained for direct injection into 
the HPLC in duplicate. Low molecular weight proteins were eluted 
as a single broad peak. Fluconazole eluted as a sharp single peak. No 
other peaks were detected. The detection limit was 0.195 pg/mL. 
Inter- and intra-run accuracies and precision fell well within the 
current guidelines for the validation of analytic methods. 
Conclusions: Ultrafiltration provides a rapid single-step proce- 
dure for extracting fluconazole plasma to measure its concentration 
by HPLC. This method is simple, precise and accurate. Moreover, it 
provides a valid method for measuring drug levels in small volumes 
of plasma. 
Miscellaneous 
Ip11861 Effect of pH on in vitro susceptibility of 
Bacteroides fragilis isolates to carbapenem 
antibiotics 
R. Edwards, M. Driver. Division CfMicrobiology and PHLS 
Laboratory, University Hospital, Queen's Medicai Centre, Notfingham, 
UK 
Objectives: To investigate the effect of low pH, frequently encoun- 
tered at infected sites, on the in vitro activity of carbapenem antibi- 
otics against B. jagilis isolates and to determine the role of 
carbapenemase activity and antibiotic stability. 
Methods: The MICs of imipenem and meropenem were deter- 
mined for 26 isolates which possessed the carbapenemase gene (&) 
and 25 cfui-negative strains using supplemented brain-heart infusion 
agar adjusted to pH 6.8, 6.2 and 5.5 with citrate-phosphate buffer. 
An inoculum of 1 O6 organisms was used and the MICs were read after 
48 h of anaerobic incubation. The stability of the carbapenem antibi- 
otics in buffer at the three pH levels was measured specmphoto- 
metrically at 299 nm over a 24-h period at 37'C. 
Results: Imipenem and meropenem showed similar activity 
against B.jagilis isolates when tested at pH 6.8. The geometric mean 
ofMICs ofimipenem for all strains tested rose from 1.9 to 19.0 mg/L 
as the pH fell from 6.8 to 5.5. This increase in imipenem resistance 
was observed with both the &4-positive and @-negative strains. 
The MICs of meropenem were only marginally affected by reduced 
pH. The spectrophotometric experiments showed imipenem to be 
markedly less stable than meropenem, particularly at pH 5.5. 
Conclusions: With decreased pH, the activity of imipenem 
against B. jagilis declined and was inferior to that of meropenem. 
This was due to the instability of imipenem and not changes in 
carbapenemase activity. 
